Charles Schwab’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200M Sell
3,129,530
-27,496
-0.9% -$1.81M 0.03% 464
2026
Q1
$225M Buy
3,157,026
+201,317
+7% +$15.9M 0.03% 385
2025
Q4
$242M Sell
2,955,709
-29,932
-1% -$2.33M 0.04% 362
2025
Q3
$224M Sell
2,985,641
-52,883
-2% -$3.94M 0.04% 375
2025
Q2
$225M Sell
3,038,524
-30,590
-1% -$2.13M 0.04% 370
2025
Q1
$248M Buy
3,069,114
+109,858
+4% +$9.44M 0.05% 319
2024
Q4
$231M Buy
2,959,256
+248,318
+9% +$21.1M 0.04% 340
2024
Q3
$254M Buy
2,710,938
+290,019
+12% +$24.3M 0.05% 307
2024
Q2
$189M Buy
2,420,919
+210,566
+10% +$17.2M 0.04% 404
2024
Q1
$201M Buy
2,210,353
+300,205
+16% +$25M 0.05% 353
2023
Q4
$148M Buy
1,910,148
+42,868
+2% +$3M 0.04% 408
2023
Q3
$127M Sell
1,867,280
-168,374
-8% -$12.3M 0.04% 418
2023
Q2
$165M Buy
2,035,654
+160,321
+9% +$12.8M 0.05% 343
2023
Q1
$154M Buy
+1,875,333
New +$134M 0.05% 355

Other funds holding GEHC

Charles Schwab's GEHC Position: Q2 2026 in Review

Charles Schwab reduced its GE HealthCare (GEHC) stake by 0.87% in Q2 2026, selling an estimated $1.81M and leaving 3,129,530 shares worth $200M. The position accounts for 0.03% of the portfolio, ranked #464.

Charles Schwab first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $254M in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Charles Schwab held 3,129,530 shares of GE HealthCare worth $200M as of Q2 2026.
  • Charles Schwab sold 27,496 GE HealthCare shares in Q2 2026, an estimated $1.81M.
  • GE HealthCare made up 0.03% of Charles Schwab's portfolio in Q2 2026, its #464 holding.
  • Charles Schwab first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Charles Schwab's GE HealthCare position peaked at $254M in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.